Monitoring patients with chronic hepatitis during and after therapy;Praćenje liječenih i neliječenih bolesnika s virusnim hepatitisom

Acta Medica Croatica

Volumn 63, Issue 5, 2009, Pages 377-383

  Čolić Cvrlje, Vesna ^a   Stjepan, Miše ^b  

^a University of Zagreb   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Hepatitis B; Hepatitis C; Monitoring; Screening

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON; NUCLEOSIDE DERIVATIVE; VIRUS RNA; ANTIVIRUS AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS DELTA VIRUS; HEPATITIS E; HIGH RISK POPULATION; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; MIXED INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT MONITORING; PROGNOSIS; QUANTITATIVE ASSAY; REVIEW; RISK FACTOR; SCREENING TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; ARTICLE; BIOPSY; BLOOD; IMMUNOLOGY; LIVER; PATHOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; BIOPSY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; RNA, VIRAL;

EID: 75749112072     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Expert Consensus Conference. The screening for hepatitis C virus in adults in Italy. Digestive and Liver Disease 2006; 38:445-51.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41.
3. Kanval F, Hoang T, Siegel BM i sur. Predictors of treatment in patients with chronic heptitis C infection-role of patient versus nonpatient factors. Hepatology 2007; 46:1741-56.
4. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Eurosurveillance 2008; 13:1-8.
5. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C in Europe. J Hepatol 2008; 48:148-62.
6. Wiessing L, Guarita B, Giraudon I i sur. European monitoring of notifications of hepatitis C virus infection in the general population and among injection drug users (IDUs)-the need to improve quality and comparability. Eurosurveillance 2008; 13:1-5.
7. Sulkowsky MS. Viral hepatitis and HIV coinfection. J Hepatol 2008; 48:353-67.
8. Kumar M, Sarin SK, Hissar S i sur. Virologic and histologic features of chronic hepatitis B virus -infected asymptomatic patients with persistenly normal ALT. Gastroenterology 2008; 134:1376-82.
9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-36.
10. Canadian Consensus Guidelines. Management of chronic hepatitis B: Consensus Guidelines. Can J Gastroenterol 2007; 21(SupplC):5-23.
11. National Institute of Health. Consensus Development Conference Statement, Management of Hepatitis B. 2008; October 20-22:1-17.
12. Buster E.H.C.J, van Erpecum K.J, Schalm S.W i sur. Treatment of chronic hepatitis B virus infection-Dutch national guidelines. Neth J Med 2008; 66:292-306.
13. Akiba J, Umemura T, Alter HJ i sur. SEN virus: epidemiology and characteristics of a transfusion-transmitted virus. Transfusion 2005; 45:1084-87.
14. Berzsenyi MD, Bowden DS, Kelly HA i sur. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology 2007; 133:1821-24.
15. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147:28-32.
16. Kamar N, Selves J, Mansuy JM i sur. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358:811-14.